Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
AN Serafini, SJ Houston, I Resche, DP Quick… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE To evaluate the effectiveness and safety of samarium-153 (153Sm) lexidronam (EDTMP)
in a double-blind, placebo-controlled study. PATIENTS AND METHODS Patients …
in a double-blind, placebo-controlled study. PATIENTS AND METHODS Patients …
[PDF][PDF] Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [18F]Fluorodeoxyglucose Positron Emission Tomography
…, E Garin, S Rouquette, I Resche… - Journal of clinical …, 2006 - researchgate.net
… Caroline Rousseau, Anne Devillers, Christine Sagan, Ludovic Ferrer, Boumédiène Bridji,
Loıc Campion, Myriam Ricaud, Emmanuelle Bourbouloux, Isabelle Doutriaux, Martine …
Loıc Campion, Myriam Ricaud, Emmanuelle Bourbouloux, Isabelle Doutriaux, Martine …
Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement
…, C Rousseau, S Bourdin, JF Chatal, I Resche - European journal of …, 2000 - Springer
This retrospective study evaluated the toxicity and efficacy of strontium-89 chloride (Metastron,
Amersham) in 94 patients with painful bone metastases of prostate cancer (117 injections …
Amersham) in 94 patients with painful bone metastases of prostate cancer (117 injections …
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma
E Mirallié, T Guillan, B Bridji, I Resche, C Rousseau… - Surgery, 2007 - Elsevier
BACKGROUND: 18-F-fluoro-2-deoxyglucose positron emission tomography ( 18 FDG-PET)
is useful in the detection of iodine-negative differentiated thyroid carcinoma (DTC). The aim …
is useful in the detection of iodine-negative differentiated thyroid carcinoma (DTC). The aim …
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial
…, A Murat, TC Ferreira, M Bardiès, L Ferrer, I Resche… - Clinical cancer …, 1999 - AACR
The toxicity and therapeutic efficacy of escalating doses of anti-carcinoembryonic antigen ×
anti-Nα-(diethylenetriamine-N,N,N′,N″-tetraacetic acid)-In bispecific monoclonal antibody (…
anti-Nα-(diethylenetriamine-N,N,N′,N″-tetraacetic acid)-In bispecific monoclonal antibody (…
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma
…, C Sagan, C Ansquer, A Testard, I Resche… - European journal of …, 2010 - Springer
Purpose The aim of this retrospective study was to evaluate the contribution of 18 F-FDG
PET to the clinical management and survival outcome of patients suspected of recurrent …
PET to the clinical management and survival outcome of patients suspected of recurrent …
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen× anti-hapten bispecific antibody-mediated pretargeting of iodine-131 …
…, JP Vuillez, PY Brard, C Rousseau, I Resche… - Clinical cancer …, 2003 - AACR
Purpose: Pharmacokinetics and dosimetry of hMN-14 × m734 bispecific monoclonal
antibody (BsMAb) and 131 I-labeled di-diethylenetriaminepentaacetic acid-indium ( 131 I-hapten) …
antibody (BsMAb) and 131 I-labeled di-diethylenetriaminepentaacetic acid-indium ( 131 I-hapten) …
Prospective comparison of 3 γ-probes for sentinel lymph node detection in 200 breast cancer patients
Previous reports have shown that axillary sentinel lymph node (ASLN) radiodetection allows
accurate axillary staging for patients with early breast cancer. Radioguided surgery implies …
accurate axillary staging for patients with early breast cancer. Radioguided surgery implies …
Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study
…, C Curtet, F Dravet, R Pioud, C Rousseau, I Resche… - Cancer, 2004 - Wiley Online Library
BACKGROUND Previous reports have shown that regional lymph node involvement in
patients with early‐stage breast carcinoma can be evaluated by resection of axillary sentinel …
patients with early‐stage breast carcinoma can be evaluated by resection of axillary sentinel …
Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary
…, C Bouriel, AM Bernard, B Bridji, I Resche - Cancer …, 2007 - Taylor & Francis
We carried out a study to evaluate the contribution of positron emission tomography with 18
F-fluorodeoxyglucose (PET-FDG) in the diagnosis and therapeutic care of patients …
F-fluorodeoxyglucose (PET-FDG) in the diagnosis and therapeutic care of patients …